- Home
- WALD
WALD
Waldencast plc
as 11-21-2024 11:40am EST
Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | WHITE PLAINS |
| Market Cap: | 336.0M | IPO Year: | 2021 |
| Target Price: | $6.08 | AVG Volume (30 days): | 57.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.40 - $12.00 | Next Earning Date: | 08-27-2024 |
| Revenue: | $240,382,000 | Revenue Growth: | -12.74% |
| Revenue Growth (this year): | 26.66% | Revenue Growth (next year): | 19.45% |
Latest Waldencast plc News
WALD Breaking Stock News: Dive into WALD Ticker-Specific Updates for Smart Investing
Exec Edge
19 hours ago
Waldencast Up 13% After Hours on Strong Q3 Results
GlobeNewswire
19 hours ago
Waldencast Reports Q3 2024 Financial Results
GuruFocus.com
a day ago
Waldencast PLC (WALD) Q3 2024: Everything You Need to Know Ahead of Earnings
GlobeNewswire
8 days ago
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
Simply Wall St.
24 days ago
October 2024's US Growth Companies With High Insider Ownership
Simply Wall St.
a month ago
Waldencast plc (NASDAQ:WALD): When Will It Breakeven?
GlobeNewswire
a month ago
Waldencast plc Announces Board Appointments and Annual General Meeting
GlobeNewswire
2 months ago
Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
Compare WALD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WALD Waldencast plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.